Announcements Trials
Browse Landscape

Phase

Phase NA 7Phase 1 1

Status

Unknown 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Urinary Bladder Neoplasms 1Tobacco Use Disorder 1Stress Disorders, Post-Traumatic 1Small Cell Lung Carcinoma 1Pancreatic Neoplasms 1Depression 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms 1

Interventions

Gemcitabine 169130-nm albumin-bound paclitaxel 54Albumin-Bound Paclitaxel 42Oxaliplatin 32Fluorouracil 31pembrolizumab 30Capecitabine 30Leucovorin 27Irinotecan 27Radiotherapy 25Nivolumab 22Erlotinib Hydrochloride 21Taxes 19Cisplatin 18Bevacizumab 15Specimen Handling 12Magnetic Resonance Spectroscopy 12Radiosurgery 11Ipilimumab 11Cyclophosphamide 11Drug Therapy 10Carboplatin 10Paclitaxel 9Docetaxel 9Cetuximab 9Biopsy 9trametinib 8olaparib 8Sorafenib 8poly ICLC 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Pancreatic Neoplasms × Methods × Clear all
NCT01219192 2010-10-28

Study of M2ES in Patients With Advanced Pancreatic Cancer After Gemcitabine Treatment Failure

Protgen Ltd

Phase 1 Unknown
24 enrolled
Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡